We are live on ! Find out more
DGX icon

Quest Diagnostics
DGX

558 hedge funds and large institutions have $11.2B invested in Quest Diagnostics in 2016 Q2 according to their latest regulatory filings, with 52 funds opening new positions, 205 increasing their positions, 197 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

61% more call options, than puts

Call options by funds: $37.9M | Put options by funds: $23.6M

27% more first-time investments, than exits

New positions opened: 52 | Existing positions closed: 41

22% more funds holding in top 10

Funds holding in top 10: 9 → 11 (+2)

21% more capital invested

Capital invested by funds: $9.29B → $11.2B (+$1.95B)

3.82% more ownership

Funds ownership: 93.85% → 97.66% (+3.8%)

4% more repeat investments, than reductions

Existing positions increased: 205 | Existing positions reduced: 197

0% more funds holding

Funds holding: 557 → 558 (+1)

Holders
558
Holders Change
+1
Holders Change %
+0.18%
% of All Funds
14.89%
Holding in Top 10
11
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+22.22%
% of All Funds
0.29%
New
52
Increased
205
Reduced
197
Closed
41
Calls
$37.9M
Puts
$23.6M
Net Calls
+$14.3M
Net Calls Change
+$1.29M

Top Buyers

1
Macquarie Group
Macquarie Group
Australia
+$685M
2
Victory Capital Management
Victory Capital Management
Texas
+$95.2M
3
American Century Companies
American Century Companies
Missouri
+$77.8M
4
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$74.6M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$54.9M

Top Sellers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$229M
2
Royal London Asset Management
Royal London Asset Management
United Kingdom
-$188M
3
Allianz Asset Management
Allianz Asset Management
Germany
-$70.2M
4
HM
HealthCor Management
New York
-$53.3M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$52.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
AG
326
Advisor Group
Arizona
$756K +$711K +9,334 New
LIA
327
LS Investment Advisors
Michigan
$755K -$24.1K -316 -3%
GL
328
GLG LLC
New York
$744K -$105K -1,375 -13%
O
329
OppenheimerFunds
New York
$723K -$30.8K -404 -4%
1GA
330
1st Global Advisors
Texas
$723K +$4.57K +60 +0.7%
HAG
331
HighPoint Advisor Group
Illinois
$723K +$644K +8,458 New
Jane Street
332
Jane Street
New York
$716K +$670K +8,795 New
LIM
333
Leavell Investment Management
Alabama
$700K -$3.58K -47 -0.5%
LMGAM
334
Liberty Mutual Group Asset Management
Massachusetts
$693K +$64.6K +848 +11%
FQ
335
First Quadrant
California
$684K -$7.16K -94 -1%
PCM
336
Piermont Capital Management
Missouri
$669K +$626K +8,220 New
CMANY
337
Capital Management Associates (New York)
New York
$651K – – –
ERSOT
338
Employees Retirement System of Texas
Texas
$651K – – –
SIM
339
Sentry Investment Management
Wisconsin
$648K – – –
GIA
340
GHP Investment Advisors
Colorado
$644K +$4.87K +64 +0.8%
APFBOT
341
Amica Pension Fund Board of Trustees
Rhode Island
$625K – – –
RJT
342
Raymond James Trust
Florida
$617K +$19.3K +253 +3%
NB
343
Norinchukin Bank
Japan
$604K +$7.01K +92 +1%
Group One Trading
344
Group One Trading
Illinois
$595K +$259K +3,400 +87%
HK
345
Horizon Kinetics
New York
$594K -$3.81K -50 -0.7%
EDRAMF
346
Edmond de Rothschild Asset Management (France)
France
$586K – – –
EDRH
347
Edmond de Rothschild Holding
Switzerland
$586K – – –
MA
348
Marshwinds Advisory
Georgia
$586K – – –
BF
349
BOK Financial
Oklahoma
$582K +$96K +1,261 +21%
CIA
350
Capital Investment Advisors
Georgia
$572K -$3.73K -49 -0.7%
12 13
14
15 16

DGX Hedge Fund Activity: Q2 2016 in Review

558 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q2 2016, worth a combined $11.2B — up 21% from $9.29B a quarter earlier.

Buyers outnumbered sellers: 52 funds opened new DGX positions and 41 closed out — a net gain of 11 holders — while 205 added to existing stakes and 197 trimmed.

The largest buyer was Macquarie Group, adding an estimated $685M. The largest seller was T. Rowe Price Associates, cutting an estimated $229M.

  • 558 institutional investors held Quest Diagnostics (DGX) as of Q2 2016, up from 557 in Q1 2016.
  • Funds reported $11.2B of Quest Diagnostics stock for Q2 2016, up 21% quarter-over-quarter.
  • 52 funds opened new Quest Diagnostics positions in Q2 2016 and 41 closed out, a net change of +11 holders.
  • The largest Quest Diagnostics buyer in Q2 2016 was Macquarie Group, an estimated $685M added.
  • The largest Quest Diagnostics seller in Q2 2016 was T. Rowe Price Associates, an estimated $229M sold.

Based on aggregated 13F filings for Q2 2016.